Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased nuclear DNA damage precedes mitochondrial dysfunction in peripheral blood mononuclear cells from Huntington’s disease patients

25 Jun 2018

Abstract excerpt

Huntington's disease (HD) is a progressive neurodegenerative disorder primarily affecting the basal ganglia and is caused by expanded CAG repeats in the huntingtin gene. Except for CAG sizing, mitochondrial and nuclear DNA (mtDNA and nDNA) parameters have not yet proven to be representative biomarkers for disease and future therapy. Here, we identified a general suppression of genes associated with aerobic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Mitochondrial Function and Pathology
Share to Neurological disorders and treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29959348
DOI: 10.1038/s41598-018-27985-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased nuclear DNA damage precedes mitochondrial dysfunction in peripheral blood mononuclear cells from Huntington’s disease patientsPMID 29959348Read ↗

Mitochondrial biology and the identification of biomarkers of Huntington's disease.Semantic proximity Read ↗

Mitochondrial DNA levels in Huntington disease leukocytes and dermal fibroblasts.Semantic proximity Read ↗

Huntington's disease affects mitochondrial network dynamics predisposing to pathogenic mitochondrial DNA mutations.Semantic proximity Read ↗

Reduction in mitochondrial DNA copy number in peripheral leukocytes after onset of Huntington's diseaseSemantic proximity Read ↗

Abnormal molecular signatures of inflammation, energy metabolism and vesicle biology in human Huntington disease peripheral tissuesSemantic proximity Read ↗

Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissuesSemantic proximity Read ↗

Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.Semantic proximity Read ↗

Mitochondrial organization and structure are compromised in fibroblasts from patients with Huntington’s diseaseSemantic proximity Read ↗

Complex I Defect in muscle from patients with Huntington's diseaseSemantic proximity Read ↗

Energy deficit in Huntington disease: why it mattersSemantic proximity Read ↗

Mitochondrial dynamics and quality control in Huntington's diseaseSemantic proximity Read ↗

Antioxidant and Anti-Inflammatory Defenses in Huntington’s Disease: Roles of NRF2 and PGC-1α, and Therapeutic StrategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.